AstraZeneca PLC revenue for the last year amounted to 52.23 B EUR, the most of which — 19.18 B EUR — came from its highest performing source at the moment, Oncology, the year earlier bringing 15.91 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought AstraZeneca PLC 20.62 B EUR, and the year before that — 16.81 B EUR.